Tag Archives: ADHD

FDA Approves Qelbree (viloxazine) for the Treatment of ADHD

FDA Approves Qelbree (viloxazine) for the Treatment of ADHD ROCKVILLE, Md., April 02, 2021 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that the U.S. Food and Drug Administration (FDA) approved Qelbree (viloxazine extended-release capsules) for the treatment of attention-deficit hyperactivity… Read More »

ADHD Can Increase The Risk Of Substance Abuse

Data analysis of 2 long-term studies on how ADHD impacts psychiatric disorder development in adolescents confirms that ADHD on its own increases the risk of substance abuse and cigarette smoking in both girls and boys significantly. The research supports the connection between substance abuse and ADHD discovered in earlier research and demonstrates that coexisting factors… Read More »